AAPS Workshop on the Role of Dissolution in QbD and Drug Product Life Cycle: A Commentary

被引:5
作者
D'Souza, Susan S. [1 ]
Lozano, Ruben [2 ]
Mayock, Stephen [3 ]
Gray, Vivian [4 ]
机构
[1] Sunovion Inc, Chem & Pharmaceut Sci, Marlborough, MA USA
[2] Bristol Myers Squibb Co, Analyt Res & Dev, New Brunswick, NJ USA
[3] Vertex Pharmaceut Inc, Cambridge, MA USA
[4] VA Gray Consulting Inc, Hockessin, DE USA
来源
DISSOLUTION TECHNOLOGIES | 2010年 / 17卷 / 04期
关键词
D O I
10.14227/DT170410P41
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This is a summary report of the "AAPS Workshop on the Role of Dissolution in QbD and Drug Product Life Cycle" organized by the AAPS In Vitro Release and Dissolution Testing (IVDRT) Focus Group. Representatives from the pharmaceutical industry, regulatory authorities, and academia in the U.S. and Europe attended this workshop to discuss the role of dissolution in a Quality by Design (QbD) setting and its relevance in drug product development. Other areas of discussion included IVIVC/R and hot topics like alcohol dose-dumping. Numerous case studies were presented, and issues relevant to the dissolution scientist and areas needing further research were highlighted at this workshop. Views expressed in this paper are those of the participants from the industry and the agency and do not necessarily represent those of the FDA and USP.
引用
收藏
页码:41 / 45
页数:5
相关论文
共 3 条
[1]   Salt formation to improve drug solubility [J].
Serajuddin, Abu T. M. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :603-616
[2]  
THAKKER K, 2008, DISSOLUT TECHNOL, V15, P39
[3]   Commentary on AAPS workshop - Dissolution testing for the twenty-first century: Linking critical quality attributes and critical process parameters to clinically relevant dissolution [J].
Tong, Cheng ;
Souza, Susan S. D. ;
Parker, Jan E. ;
Mirza, Tahseen .
PHARMACEUTICAL RESEARCH, 2007, 24 (09) :1603-1607